PMID: 6973337Mar 1, 1981Paper

Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale

The Australian and New Zealand Journal of Psychiatry
J M ReyG F Johnson

Abstract

Psychiatric outpatients were assessed for dyskinetic movements using the abnormal involuntary movement scale (AIMS). The prevalence of tardive dyskinesia in an Australian sample of 66 patients was 44% which is similar to reported prevalence in other countries. Although the prevalence was significantly higher in patients over 45 years of age and with more than a 5 year history of neuroleptic medication, there were no significant correlations between presence of dyskinesias and age, sex or duration of neuroleptic treatment. Organic factors such as neurological disorders, ECT or alcoholism were not related to dyskinetic movements, nor was the use of anticholinergic or tricyclic antidepressant medication. The AIMS is a reliable rating scale for dyskinetic movements and could be used more widely as a screening instrument for early detection of tardive dyskinesia.

Associated Clinical Trials

Jan 16, 2008·David C. Henderson, David C. Henderson

References

May 1, 1979·Archives of General Psychiatry·D V JesteR J Wyatt
Aug 1, 1979·Danish Medical Bulletin·J Gerlach
Jan 1, 1979·Psychopharmacology·D E CaseyH Simmelsgaard
Dec 15, 1979·Lancet·J Hyttel, I M Nielsen
Jun 28, 1979·Psychopharmacology·J M SmithC Linn
Aug 8, 1979·Psychopharmacology·G M SimpsonG Gardos
Dec 1, 1977·The American Journal of Psychiatry·G M AsnisA H Schwartz
Jul 1, 1979·The American Journal of Psychiatry·J M SmithL J Waterman
Sep 1, 1977·Acta Neurologica Scandinavica·P J Delwaide, M Desseilles
Oct 1, 1977·Archives of General Psychiatry·G GardosR La Brie
Mar 1, 1975·Clinical Endocrinology·P Marsden, C G McKerron
Feb 1, 1976·The American Journal of Cardiology·S WolfsonL S Cohen
May 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·W E FannB W Richman
Oct 1, 1972·Archives of General Psychiatry·H KazamatsuriJ O Cole
Sep 22, 1973·The Medical Journal of Australia·L G KilohS E Williams
May 31, 1971·JAMA : the Journal of the American Medical Association·H D SutcherO Sugar
Mar 1, 1980·The Journal of Nervous and Mental Disease·M BourgeoisJ Yesavage
Jan 1, 1980·Advances in Biochemical Psychopharmacology·D E CaseyT R Christensen
Jan 1, 1964·Acta Psychiatrica Scandinavica·A Faurbye, J Clausen
Jan 1, 1964·Acta Psychiatrica Scandinavica·A FaurbyeH Pakkenberg

❮ Previous
Next ❯

Citations

May 19, 2009·The Journal of Dairy Research·Nidhi BansalPaul L H McSweeney
Apr 14, 2011·Journal of Child and Adolescent Psychopharmacology·Judit BalázsJúlia Gádoros
Feb 4, 2014·Current Psychiatry Reports·Danielle A Baribeau, Evdokia Anagnostou
Jan 1, 1990·The American Journal of Drug and Alcohol Abuse·A A OliveraN K Manley
Nov 20, 2016·Journal of Attention Disorders·Ágnes KeresztényJudit Balázs
Nov 1, 1987·Acta Psychiatrica Scandinavica·J M RaoB Mathew
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·A Negrotti, S Calzetti
Dec 1, 1984·The Journal of the Oklahoma State Medical Association·J R Allen
Apr 23, 2013·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Connie G ChiuMargaret I Fitch
May 1, 1995·The American Journal of Drug and Alcohol Abuse·D A D'MelloB Msibi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here